Research Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.
College of Pharmacy, Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Inje-ro, Gimhae, Gyeongnam 50834, Republic of Korea.
J Org Chem. 2021 Mar 19;86(6):4375-4390. doi: 10.1021/acs.joc.0c02573. Epub 2021 Jan 19.
Many optically active 2-azaspirocyclic structures have frequently been found in biologically active natural products. In particular, alkaloids, (+)-nitramine, (+)-isonitramine, (-)-isonitramine, and (-)-sibirine, have stereogenicity on their quaternary carbon of the 2-azaspiro[5,5]undecane-7-ol structure. To synthesize alkaloids, we developed a new enantioselective synthetic method for chiral α-quaternary lactams via the α-alkylation of α--butoxycarbonyl lactams. α-Alkylation of α--butoxycarboxylactams in the circumstances of phase-transfer catalytic (PTC) system (solid KOH, toluene, and -40 °C) by virtue of the catalytic action of (,)-NAS bromide (5 mol %) furnished the corresponding α-alkyl-α--butoxycarbonyl lactams in very high chemical (<99%) and enantioselectivity (<98% ee). Our catalytic methodology was successfully applied for the enantioselective total synthesis of alkaloids. (+)-Isonitramine was obtained in 12 steps (98% ee, 43% yield) from δ-valerolactam through enantioselective phase-transfer catalytic allylation, Dieckmann condensation, and diastereoselective reduction as the key reactions. (-)-Sibirine and (+)-nitramine were prepared from (-)-isonitramine or its intermediate. Switching the phase-transfer catalyst from (,)-NAS bromide to (,)-NAS bromide afforded (-)-isonitramine (98% ee, 41% yield). (-)-Sibirine was synthesized by -ethoxycarbonylation of (-)-isonitramine followed by reduction (98% ee, 14 steps, 32% yield). Furthermore, the diastereoselective reduction of ()-2-benzhydryl-2-azaspiro[5.5]undecane-1,7-dione [()-] followed by reductive removal of the diphenylmethyl group successfully gave (+)-nitramine (98% ee, 11 steps, 40% yield).
许多具有光学活性的 2-氮杂螺环结构经常在生物活性天然产物中被发现。特别是生物碱、(+)-硝胺、(+)-异硝胺、(-)-异硝胺和(-)-西伯利因,在其 2-氮杂螺[5.5]十一烷-7-醇结构的季碳原子上具有手性。为了合成生物碱,我们开发了一种通过α-烷化α--丁氧基羰基内酰胺来合成手性α-季铵内酰胺的新的对映选择性合成方法。在相转移催化(PTC)体系(固体 KOH、甲苯和-40°C)中,通过(,)-NAS 溴化物(5 mol%)的催化作用,α--丁氧基羰酰内酰胺的α-烷基化反应非常高的化学收率(<99%)和对映选择性(<98%ee)得到相应的α-烷基-α--丁氧基羰酰内酰胺。我们的催化方法成功地应用于生物碱的对映选择性全合成。(+)-异硝胺是通过δ-戊内酰胺的对映选择性相转移催化烯丙基化、迪克曼缩合和非对映选择性还原反应作为关键反应,以 12 步(98%ee,43%产率)从(-)-异硝胺制备得到。(-)-西伯利因和(+)-硝胺是从(-)-异硝胺或其中间体制备的。将相转移催化剂从(,)-NAS 溴化物切换为(,)-NAS 溴化物得到(-)-异硝胺(98%ee,41%产率)。(-)-西伯利因是通过(-)-异硝胺的-乙氧基羰基化反应,然后还原反应(98%ee,14 步,32%产率)得到。此外,()-2-二苯甲基-2-氮杂螺[5.5]十一烷-1,7-二酮[()]的非对映选择性还原反应,然后还原去除二苯甲基基团,成功地得到(+)-硝胺(98%ee,11 步,40%产率)。